Current Medicinal Chemistry - Anti-Cancer Agents

Preface
pp. i-i(1)
Author: Fabbro, D.

Chemical and Biological Profile of Dual Cdk1 and Cdk2 Inhibitors
pp. 1-14(14)
Authors: Ruetz, S.; Fabbro, D.; Zimmermann, J.; Meyer, T.; Gray, N.

X-Ray Crystallographic Studies of CDK2, a Basis for Cyclin-Dependent Kinase Inhibitor Design in Anti-Cancer Drug Research
pp. 15-23(9)
Author: Furet, P.

Structure-Based Design of Novel Anti-Cancer Agents TargetingAurora Kinases
pp. 25-34(10)
Authors: Mahadevan, D.; Bearss, D.J.; Vankayalapati, H.

Potentiation of DNA-Damage-Induced Cytotoxicity by G2Checkpoint Abrogators
pp. 35-46(12)
Authors: Tenzer, A.; Pruschy, M.

Cyclin-Dependent Kinase Modulators Studied at the NCI: Pre-Clinical and Clinical Studies
pp. 47-56(10)
Author: Sausville, E.A.

Peptidomimetic Design of CDK Inhibitors Targeting theRecruitment Site of the Cyclin Subunit
pp. 57-69(13)
Authors: McInnes, C.; Andrews, M.J.; Zheleva, D.I.; Lane, D.P.; Fischer, P.M.

Author Index To Volume 2
pp. 71-72(2)
Author: Bentham, S.

Subject Index To Volume 2
pp. 73-76(4)
Author: Bentham, S.